Sage Journals: Discover world-class research

Sort by:

Relevance

Select allExport selected citations

Sort by:

Relevance

Open access

Review article

First published 2013

Review of Treatment Options for Myelofibrosis: Focus on Ruxolitinib

Donal P. McLornan, John Laurie, Claire N. Harrison

Clinical Medicine Insights: Therapeutics

Retricted access

Case report

First published 2020-6

Ruxolitinib for the treatment of lymphoma-associated hemophagocytic lymphohistiocytosis: A cautionary tale

Tanner Trantham, Jessica Auten, Benyam Muluneh [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2023-8

Review of Ruxolitinib for Treatment of Non-Segmental Vitiligo

Jacqueline R. Hwang, Marcia S. Driscoll

Annals of Pharmacotherapy

Retricted access

Case report

First published 2017-11

A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata

Maya Deeb, Renée A. Beach

Journal of Cutaneous Medicine and Surgery

Retricted access

Review article

First published 2017-4

Experience with ruxolitinib in the treatment of polycythaemia vera

Samah Alimam, Claire Harrison

Therapeutic Advances in Hematology

Open access

Case report

First published 2021

COVID-19 in a patient with SISTEMIC sclerosis: The role of ruxolitinib

Claudio Ucciferri, Antonio Auricchio, Stefano Marinari [...]

European Journal of Inflammation

Retricted access

Case report

First published 2022-6

Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease

Burcu Aslan Candır, Tuğçe Nur Yiğenoğlu, Merih Kızıl Çakar [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2018-4

Persistent foot ulcer due to ruxolitinib therapy for primary myelofibrosis

Michael Del Rosario, Henry Tsai, Constantin A Dasanu

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2012-12

Ruxolitinib: a potent and selective Janus kinase 1 and 2 inhibitor in patients with myelofibrosis. An update for clinicians

Claire Harrison, Alessandro M. Vannucchi

Therapeutic Advances in Hematology

Open access

Brief report

First published 2024

A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis

Tim Kong, Nicole Gaudin, Karyn Gordon [...]

Therapeutic Advances in Hematology

Search results